Phototherapeutic Keratectomy for Salzmannʼs Nodular Degeneration. What Effect Does the Choice of Excimer Laser Have on Treatment Success?

Abstract

Purpose The aim of this study was to assess the difference in treatment success after phototherapeutic keratectomy (PTK) for Salzmannʼs nodular degeneration (SND) using two excimer lasers with different specifications.

Patients and Methods 272 PTK procedures, which had been performed on 246 eyes with SND from 181 patients, were retrospectively examined in the period from 2007 to 2017. Until 2014 the excimer laser MEL70 (Carl Zeiss Meditec Vertriebsgesellschaft mbH, Oberkochen, Germany) was used for PTK following manual pannectomy, and after 2014 the excimer laser Amaris 750S (Schwind eye-tech-solutions GmbH, Kleinostheim, Germany) was used. Treatment success was assessed on basis of visual acuity, refraction, and astigmatism, as well as pachymetry and endothelial cell count, recorded at the following time points: T1 = preoperative, T2 = 6-week follow-up, T3 = 6-month follow-up. The Wilcoxon-Mann-Whitney U test and the chi-square test with a significance level of 5% were used to compare the data.

Results A significantly higher improvement of 0.17 ± 0.33 logMAR could be shown for visual acuity in the Schwind group (p < 0.013) after 6 months. In the Zeiss group, visual acuity improved by only 0.11 ± 0.36 (logMAR p < 0.057). Regarding refraction, a significant reduction of the spherical equivalent (SEQ) (p < 0.001) by 3.35 ± 2.76 diopters (D) after 6 months could only be shown for the Schwind group. SEQ did not change significantly in the Zeiss group (p < 0.676). The topographic astigmatism was significantly improved after 6 months in both study groups, by 1.73 ± 1.99 D in the Schwind group (p < 0.001) and by 1.99 ± 2.21 D in the Zeiss group (p < 0.0001). Haze had to be treated in 12.7% of the cases in the Schwind group and in 16.2% of the cases in the Zeiss group. No endothelial cell damage was found in either group.

Conclusions In both study groups, the patients with SND clearly benefited from PTK. However, a significantly higher advantage for visual acuity and refraction was shown for the Schwind group compared with the Zeiss group. In contrast to the usual hyperopic effect of PTK in other diagnoses, PTK in SND showed a “myopic shift”, which can be explained by the often midperipheral SND nodes and the associated asymmetric tear film pooling prior to surgery.

Key words

phototherapeutic keratectomy - Salzmann nodular degeneration - excimer laser - Amaris 750S Schwind - MEL70 Zeiss

Publication History

Received: 08 November 2021

Accepted: 14 February 2022

Article published online:
18 May 2022

• Literatur/References

• 1 Khaireddin R, Katz T, Baile RB. et al. Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmannʼs nodular degeneration: A follow-up of eight eyes. Graefes Arch Clin Exp Ophthalmol 2011; 249: 1211-1215 DOI: 10.1007/s00417-011-1643-7.
• 2 Roszkowska AM, Aragona P, Spinella R. et al. Morphologic and confocal investigation on Salzmann nodular degeneration of the cornea. Invest Ophthalmol Vis Sci 2011; 52: 5910-5919 DOI: 10.1167/jovs.11-7789.
• 3 Das S, Link B, Seitz B. Salzmannʼs nodular degeneration of the cornea: a review and case series. Cornea 2005; 24: 772-777 DOI: 10.1097/01.ico.0000153100.74033.ef.
• 4 Graue-Hernandez EO, Mannis MJ, Eliasieh K. et al. Salzmann nodular degeneration. Cornea 2010; 29: 283-289 DOI: 10.1097/ICO.0b013e3181b7658d.
• 5 Hamada S, Darrad K, McDonnell PJ. Salzmannʼs nodular corneal degeneration (SN- CD): clinical findings, risk factors, prognosis and the role of previous contact lens wear. Eye Contact Lens 2011; 34: 173-178 DOI: 10.1016/j.clae.2011.02.004.
• 6 Severin M, Kirchhof B. Recurrent Salzmannʼs corneal degeneration. Graefes Arch Clin Exp Ophthalmol 1990; 228: 101-104 DOI: 10.1007/bf00935715.
• 7 Maharana PK, Sharma N, Das S. et al. Salzmannʼs Nodular Degeneration. Ocul Surf 2016; 14: 20-30 DOI: 10.1016/j.jtos.2015.08.006.
• 8 Papanikolaou T, Goel S, Jayamanne DGR. et al. Familial pattern of Salzmann-type nodular corneal degeneration – a four generation series. Ophthalmology 2010; 94: 1543 DOI: 10.1136/bjo.2009.177055.
• 9 Gatzioufas Z, Hager T, El-Husseiny M. et al. Salzmannʼsche noduläre Degeneration 20 Jahre nach perforierender Keratoplastik bei Keratokonus. Ophthalmologe 2011; 108: 963-965 DOI: 10.1007/s00347-011-2361-6.
• 10 Viestenz A, Bischoff-Jung M, Langenbucher A. et al. Phototherapeutic Keratectomy in Salzmann Nodular Degeneration With “Optical Cornea Plana”. Cornea 2016; 35: 843-846 DOI: 10.1097/ICO.0000000000000816.
• 11 Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res 2015; 49: 17-45 DOI: 10.1016/j.preteyeres.2015.07.002.
• 12 Qiu J, Cai R, Zhang C. Association between poor wound healing and the formation of Salzmann nodules. J Cataract Refract Surg 2016; 42: 1527-1530 DOI: 10.1016/j.jcrs.2016.07.019.
• 13 Pogorelov P, Langenbucher A, Kruse F. et al. Long-term results of phototherapeutic keratectomy for corneal map-dot-fingerprint dystrophy (Cogan-Guerry). Cornea 2006; 25: 774-777 DOI: 10.1097/01.ico.000021480.02195.d4.
• 14 Lee WS, Lam CK, Manche EE. Phototherapeutic keratectomy for epithelial basement membrane dystrophy. Clin Ophthalmol 2017; 11: 15-22 DOI: 10.2147/OPTH.S122870.
• 15 Das S, Langenbucher A, Pogorelov V. et al. Long-term outcome of excimer laser phototherapeutic keratectomy for treatment of Salzmannʼs nodular degeneration. J Cataract Refract Surg 2005; 31: 1386-1391 DOI: 10.1016/j.jcrs.2004.12.037.
• 16 Seitz B, Lisch W, Weiss J. Die revidierte neueste IC³D-Klassifikation der Hornhautdystrophien. Klin Monbl Augenheilkd 2015; 232: 283-294 DOI: 10.1055/s-0041-100774.
• 17 Szentmáry N, Seitz B, Langenbucher A. et al. Histologic and ultrastructural changes in corneas with granular and macular dystrophy after excimer laser phototherapeutic keratectomy. Cornea 2006; 25: 257-263 DOI: 10.1097/01.ico.0000176603.87376.d8.
• 18 Fantes FE, Hanna KD, Waring 3rd GO. et al. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol 1990; 108: 665-675 DOI: 10.1001/archopht.1990.01070070051034.
• 19 Seitz B, Lisch W. Stage-related therapy of corneal dystrophies. Dev Ophthalmol 2011; 48: 116-153 DOI: 10.1159/000324081.
• 20 Meek KM, Knupp C. Corneal structure and transparency. Prog Retin Eye Res 2015; 49: 1-16 DOI: 10.1016/j.preteyeres.2015.07.001.
• 21 Rashad MA. Pentacam-based phototherapeutic keratectomy outcome in superficial corneal opacities. Clin Ophthalmol 2012; 6: 885-894 DOI: 10.2147/OPTH.S31086.
• 22 Seitz B, Langenbucher A. Phototherapeutic Keratectomy in corneal Dystrophies. In: Reinhard T, Larkin F. eds. Essentials in Ophthalmology – corneal and external Eye Disease. Berlin: Springer; 2008: 55-82
• 23 Guglielmetti S, Kirton A, Reinstein DZ. et al. Repair of Irregularly Irregular Astigmatism by Transepithelial Phototherapeutic Keratectomy. J Refract Surg 2017; 33: 714-719 DOI: 10.3928/1081597X-20170721-04.